Smoking Behaviors
81
18
25
41
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
13 trials with published results (16%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.2%
1 terminated out of 81 trials
97.6%
+11.1% vs benchmark
1%
1 trials in Phase 3/4
32%
13 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 41 completed trials
Clinical Trials (82)
A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System Products
Human Perception of Odors and Odor Blockers
Multi-Site Trial of Tirzepatide for Smoking Cessation
Switch or Quit R01
Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking
Omega-3 Plus Low-Dose Aspirin in Smokers With Stage III Periodontitis
Abuse Liability of Four Modern Oral Nicotine Products
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
Vape Use Among Younger & Older Smokers
An Experimental Evaluation of Menthol-Flavored Tobacco Accessories
Translational Research Center in Lung Cancer Disparities (TRACER) Project 2
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
Abuse Liability of Two Modern Oral Nicotine Pouched Products
Smoking Cessation With Wearables to Improve General, Oral Health and Quality of Life
Nurse-led Smoking Cessation Program With Follow-up in Healthy Life Centres: a Randomized Clinical Trial
Therapeutic Contact Intensity in a Psychological Smoking Cessation Intervention With an App
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability
ACT Lung Health Intervention: Phase Two